| Accessed care after baseline CHC [N] | Retained in care at original site [n (%)] | Documented transfer [n (%)] | Died [n(%)] | Alive & in the community [n(%)] | Moved out of community [n(%)] | Missing [n(%)] | |
|---|---|---|---|---|---|---|---|
| Total | 5683 | 5058 (89.0%) | 260 (4.6%) | 60 (1.1%) | 108 (1.9%) | 64 (1.1%) | 134 (2.4%) |
| New to care | |||||||
| Total | 1601 | 1329 (83.0%) | 83 (5.2%) | 25 (1.6%) | 86 (5.4%) | 45 (2.8%) | 33 (2.0%) |
| Uganda-East | 278 | 227 (81.7%) | 6 (2.2%) | 10 (3.6%) | 22 (7.9%) | 11 (4.0%) | 2 (0.7%) |
| Uganda-West | 563 | 465 (82.6%) | 27 (4.8%) | 6 (1.1%) | 35 (6.2%) | 22 (3.9%) | 8 (1.4%) |
| Kenya | 760 | 637 (83.8%) | 50 (6.6%) | 9 (1.2%) | 29 (3.8%) | 12 (1.6%) | 31 (4.0%) |
| Men | 642 | 547 (85.2%) | 22 (3.4%) | 9 (1.4%) | 44 (6.9%) | 11 (1.7%) | 9 (1.5%) |
| Women | 959 | 782 (81.5%) | 61 (6.4%) | 16 (1.7%) | 42 (4.4%) | 34 (3.6%) | 24 (2.5%) |
| Age 15–24 | 257 | 173 (67.3%) | 23 (9.0%) | 6 (2.3%) | 24 (9.3%) | 24 (9.3%) | 7 (2.7%) |
| Age 25–29 | 308 | 247 (80.2%) | 13 (4.2%) | 5 (1.6%) | 23 (7.5%) | 10 (3.3%) | 10 (3.2%) |
| Age >= 30 | 1036 | 909 (87.7%) | 47 (4.5%) | 14 (1.4%) | 39 (3.8%) | 11 (1.1%) | 16 (1.5%) |
| Low CD4 | 766 | 595 (77.7%) | 59 (7.7%) | 20 (2.6%) | 39 (5.1%) | 26 (3.4%) | 27 (3.5%) |
| High CD4 | 835 | 734 (87.9%) | 24 (2.9%) | 5 (0.6%) | 47 (5.6%) | 19 (2.3%) | 6 (0.7%) |
| Stable resident | 1548 | 1288 (83.2%) | 81 (5.2%) | 24 (1.6%) | 82 (1.6%) | 42 (2.7%) | 25 (1.6%) |
| Not stable resident | 53 | 41 (77.4%) | 2 (3.8%) | 1 (1.9%) | 4 (7.6%) | 3 (5.7%) | 1 (1.9%) |
| Tested at CHC | 1173 | 965 (82.5%) | 63 (5.4%) | 21 (1.8%) | 64 (5.5%) | 33 (2.8%) | 27 (2.3%) |
| Tested in HBT | 428 | 364 (85.1%) | 20 (4.7%) | 4 (0.9%) | 22 (5.1%) | 12 (2.8%) | 6 (1.4%) |
| <= 30 days to link | 960 | 817 (85.1%) | 43 (4.5%) | 17 (1.8%) | 38 (4.0%) | 28 (2.9%) | 17 (1.8%) |
| > 30 days to link | 641 | 512 (79.9%) | 40 (6.2%) | 8 (1.3%) | 48 (7.5%) | 17 (2.7%) | 16 (2.5%) |
| Previously in care | |||||||
| Total | 4082 | 3729 (91.4%) | 177 (4.3%) | 35 (0.9%) | 22 (0.5%) | 18 (0.4%) | 101 (2.5%) |
| Uganda-East | 396 | 356 (89.9%) | 16 (4.0%) | 9 (2.3%) | 7 (1.8%) | 5 (1.3%) | 3 (0.8%) |
| Uganda-West | 743 | 653 (87.9%) | 78 (10.5%) | 4 (0.5%) | 1 (0.1%) | 3 (0.4%) | 4 (0.5%) |
| Kenya | 2943 | 2720 (92.4%) | 83 (2.8%) | 22 (0.8%) | 14 (0.5%) | 10 (0.3%) | 94 (3.2%) |
| Men | 1221 | 1119 (91.7%) | 46 (3.8%) | 14 (1.2%) | 12 (1.0%) | 4 (0.3%) | 26 (2.2%) |
| Women | 2861 | 2610 (91.2%) | 131 (4.6%) | 21 (0.7%) | 10 (0.4%) | 14 (0.5%) | 75 (2.6%) |
| Age 15–24 | 346 | 300 (86.7%) | 18 (5.2%) | 4 (1.2%) | 4 (1.2%) | 3 (0.9%) | 17 (4.9%) |
| Age 25–29 | 583 | 525 (90.1%) | 24 (4.1%) | 8 (1.4%) | 5 (22.7%) | 6 (1.0%) | 15 (2.5%) |
| Age >= 30 | 3153 | 2904 (92.1%) | 135 (4.3%) | 23 (0.7%) | 13 (0.4%) | 9 (0.3%) | 69 (2.2%) |
| Low CD4 | 3660 | 3330 (91.0%) | 166 (4.5%) | 34 (0.9%) | 15 (0.4%) | 15 (0.4%) | 100 (2.7%) |
| High CD4 | 422 | 399 (94.6%) | 11 (2.6%) | 1 (0.2%) | 7 (1.7%) | 3 (0.7%) | 1 (0.2%) |
| Stable resident | 3996 | 3651 (91.4%) | 172 (4.3%) | 34 (0.9%) | 21 (0.5%) | 17 (0.4%) | 101 (2.5%) |
| Not stable resident | 86 | 78 (90.7%) | 5 (5.8%) | 1 (1.2%) | 1 (1.2%) | 1 (1.2%) | 0 |
| Tested at CHC | 3213 | 2945 (91.7%) | 134 (4.2%) | 29 (0.9%) | 17 (0.5%) | 13 (0.4%) | 86 (2.7%) |
| Tested in HBT | 858 | 784 (91.4%) | 43 (5.0%) | 6 (0.7%) | 5 (0.6%) | 5 (0.6%) | 15 (1.7%) |
Low CD4 = Pre-ART CD4 below Country treatment guidelines
High CD4 = Pre-ART CD4 above Country treatment guidelines
CHC = Community Health Campaign
HBT = Home-based Testing